Latest Revenue Growth News

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

archTIS Limited has secured A$7.5 million through a discounted share placement to fund expansion in the U.S. defence sector, deepen strategic partnerships, and accelerate product innovation focused on secure data collaboration.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

Vinyl Group unveils its FY26 vision, shifting focus from growth to scalable profitability by leveraging AI-driven technology to connect millions of music creators, fans, and brands.

Biome Australia has reported record-breaking sales revenue for FY25, driven by strong domestic demand and promising international expansion. The company is on track to deliver its first full-year net profit and meet ambitious growth targets.

Southern Cross Media Group has finalized the sale of its remaining television assets, fully committing to its 'All About Audio' strategy with a 5% rise in audio revenues for FY25 and a renewed focus on debt reduction and dividends.

SciDev Limited has confirmed winning $21.5 million in new and renewed contracts spanning key industrial sectors, reinforcing its position in specialty water treatment solutions.

SenSen Networks has successfully completed a key contract with Montréal’s Agence de mobilité durable, driving record full-year revenue growth exceeding 20%. The company anticipates strong cash collections into FY26, underscoring its expanding global footprint in AI-driven urban management.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Aerometrex has renewed and extended its multi-million dollar agreement with Landchecker, significantly increasing its annual recurring revenue through the MetroMap platform.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.